Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma.

JAAD Case Rep

Department of Dermatology, Henry Ford Health System, Detroit, Michigan.

Published: March 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857547PMC
http://dx.doi.org/10.1016/j.jdcr.2022.01.005DOI Listing

Publication Analysis

Top Keywords

severe cutaneous
4
cutaneous drug
4
drug toxicity
4
toxicity enfortumab
4
enfortumab vedotin
4
vedotin treatment
4
treatment metastatic
4
metastatic urothelial
4
urothelial carcinoma
4
severe
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!